Hiroshi Ariyama

2.3k total citations
84 papers, 1.4k citations indexed

About

Hiroshi Ariyama is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Hiroshi Ariyama has authored 84 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 25 papers in Pulmonary and Respiratory Medicine and 14 papers in Molecular Biology. Recurrent topics in Hiroshi Ariyama's work include Colorectal Cancer Treatments and Studies (21 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Cancer Treatment and Pharmacology (14 papers). Hiroshi Ariyama is often cited by papers focused on Colorectal Cancer Treatments and Studies (21 papers), Cancer Immunotherapy and Biomarkers (14 papers) and Cancer Treatment and Pharmacology (14 papers). Hiroshi Ariyama collaborates with scholars based in Japan, United States and United Kingdom. Hiroshi Ariyama's co-authors include Eishi Baba, Hitoshi Kusaba, Koichi Akashi, Kenji Mitsugi, Mamoru Ito, Risa Tanaka, Kenji Tsuchihashi, Shuji Nakano, Hirofumi Ohmura and Taito Esaki and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Hiroshi Ariyama

77 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroshi Ariyama Japan 20 804 426 290 280 259 84 1.4k
Stefania Marsili Italy 22 732 0.9× 386 0.9× 388 1.3× 187 0.7× 239 0.9× 55 1.5k
Y-J. Bang South Korea 20 720 0.9× 352 0.8× 559 1.9× 175 0.6× 276 1.1× 54 1.3k
Lei Cai China 19 691 0.9× 510 1.2× 250 0.9× 172 0.6× 300 1.2× 53 1.3k
Jean Mendiboure France 12 945 1.2× 410 1.0× 412 1.4× 504 1.8× 165 0.6× 17 1.6k
Hideya Takeuchi Japan 17 584 0.7× 371 0.9× 358 1.2× 314 1.1× 223 0.9× 70 1.3k
Anwaar Saeed United States 18 964 1.2× 280 0.7× 365 1.3× 167 0.6× 386 1.5× 167 1.4k
Yoon Dae Han South Korea 19 774 1.0× 201 0.5× 231 0.8× 240 0.9× 418 1.6× 90 1.2k
Wenju Chang China 20 535 0.7× 403 0.9× 292 1.0× 210 0.8× 313 1.2× 79 1.3k
M Miyamoto Japan 20 713 0.9× 481 1.1× 216 0.7× 496 1.8× 406 1.6× 41 1.6k

Countries citing papers authored by Hiroshi Ariyama

Since Specialization
Citations

This map shows the geographic impact of Hiroshi Ariyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Ariyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Ariyama more than expected).

Fields of papers citing papers by Hiroshi Ariyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Ariyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Ariyama. The network helps show where Hiroshi Ariyama may publish in the future.

Co-authorship network of co-authors of Hiroshi Ariyama

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Ariyama. A scholar is included among the top collaborators of Hiroshi Ariyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Ariyama. Hiroshi Ariyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohmura, Hirofumi, Mamoru Ito, Kenji Tsuchihashi, et al.. (2024). Treatment of malignant primary cardiac tumors requires attention to cardiovascular complications: a single-center, retrospective study. Japanese Journal of Clinical Oncology. 55(2). 113–122.
2.
Matsumura, Takashi, Kenji Tsuchihashi, Takeo Yamamoto, et al.. (2024). Lymphoproliferative Disorder in an Esophageal Cancer Patient Treated with Pembrolizumab. Internal Medicine. 64(11). 1728–1732. 2 indexed citations
3.
Okuma, Hitomi Sumiyoshi, Kenji Tsuchihashi, Ryunosuke Machida, et al.. (2023). Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial). Clinical Cancer Research. 29(24). 5079–5086. 7 indexed citations
4.
Ito, Mamoru, Michitaka Nakano, Hiroshi Ariyama, et al.. (2022). Macrophages are primed to transdifferentiate into fibroblasts in malignant ascites and pleural effusions. Cancer Letters. 532. 215597–215597. 13 indexed citations
5.
Tsuchihashi, Kenji, Hirofumi Ohmura, Toshihiro Yamaguchi, et al.. (2020). RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells. Biochemical and Biophysical Research Communications. 530(1). 235–239. 69 indexed citations
6.
Yamaguchi, Toshihiro, Mamoru Ito, Hirofumi Ohmura, et al.. (2020). Helper T cell-dominant tertiary lymphoid structures are associated with disease relapse of advanced colorectal cancer. OncoImmunology. 9(1). 1724763–1724763. 56 indexed citations
7.
Ohmura, Hirofumi, Toshihiro Yamaguchi, Mamoru Ito, et al.. (2020). OX40 and LAG3 are associated with better prognosis in advanced gastric cancer patients treated with anti-programmed death-1 antibody. British Journal of Cancer. 122(10). 1507–1517. 51 indexed citations
8.
Nakano, Michitaka, et al.. (2017). Tumor infiltrating lymphocytes in malignant ascites predict prognosis of gastrointestinal cancer. 1242. 1 indexed citations
9.
Tsuchihashi, Kenji, Kenta Nio, Taku Yokoyama, et al.. (2017). Metastatic esophageal cancer presenting as shock by injury of vagus nerve mimicking baroreceptor reflex. Medicine. 96(49). e8987–e8987. 1 indexed citations
10.
Shirakawa, Tsuyoshi, Michitaka Nakano, Kenta Nio, et al.. (2016). Retrospective analysis of cardiovascular diseases related to chemotherapies for advanced solid tumor patients. Anti-Cancer Drugs. 27(9). 891–898. 2 indexed citations
11.
Arita, Shuji, Koji Mishima, Mamoru Tanaka, et al.. (2016). Bi-cytopenia possibly induced by anti-PD-1 antibody for primary malignant melanoma of the esophagus. Medicine. 95(29). e4283–e4283. 29 indexed citations
12.
Nio, Kenta, Shuji Arita, Taichi Isobe, et al.. (2015). Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy. Cancer Chemotherapy and Pharmacology. 75(4). 829–835. 14 indexed citations
13.
Shirakawa, Tsuyoshi, et al.. (2015). Improvement in the awareness of palliative care nursing using STAS-J in an acute care hospital. Annals of Oncology. 26. vii88–vii88.
14.
Tamura, Shingo, Hitoshi Kusaba, Naoki Kubo, et al.. (2014). Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer. Medical Oncology. 31(3). 856–856. 6 indexed citations
15.
Isobe, Taichi, Keita Uchino, Hiroshi Ariyama, et al.. (2014). Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.. PubMed. 34(4). 2035–40. 11 indexed citations
16.
Shibata, Wataru, Hiroshi Ariyama, C. Benedikt Westphalen, et al.. (2013). Stoma cell-derived factor-1 overexpression induces gastric dysplasia through expansion of stromal myofibroblasts and epithelial progenitors. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 59 indexed citations
17.
Baba, Eishi, Taito Esaki, Hiroshi Ariyama, et al.. (2010). Phase II study of sequential treatment with S-1 and cisplatin for metastatic gastric cancer. Cancer Chemotherapy and Pharmacology. 68(3). 611–617. 1 indexed citations
18.
Shibata, Yoshihiro, Eishi Baba, Hiroshi Ariyama, et al.. (2010). Irinotecan-based combination chemotherapy for metastatic small intestinal adenocarcinoma. Oncology Letters. 1(3). 423–426. 1 indexed citations
19.
Kato, Ken, Kenji Mitsugi, Minoru Nakamura, et al.. (2005). Feasibility study of ambulatory continuous infusion of 5-fluorouracil followed by cisplatin through hepatic artery for metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 57(1). 114–119. 3 indexed citations
20.
Tanaka, Risa, Yasushi Takii, Yoshihiro Shibata, et al.. (2005). In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines. Cancer Chemotherapy and Pharmacology. 56(3). 279–285. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefania Marsili Breakdown of academic impact, for papers by Y-J. Bang Breakdown of academic impact, for papers by Lei Cai Breakdown of academic impact, for papers by Jean Mendiboure Breakdown of academic impact, for papers by Hideya Takeuchi Breakdown of academic impact, for papers by Anwaar Saeed Breakdown of academic impact, for papers by Yoon Dae Han Breakdown of academic impact, for papers by Wenju Chang Breakdown of academic impact, for papers by M Miyamoto
Rankless by CCL
2026